| Year |
Citation |
Score |
| 2024 |
Moein Taghavi H, Karimpoor M, van Staalduinen EK, Young CB, Georgiadis M, Leventis S, Carlson M, Romero A, Trelle A, Vossler H, Yutsis M, Rosenberg J, Davidzon GA, Zaharchuk G, Poston K, ... ... Mormino E, et al. Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET-MR. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e70040. PMID 39583648 DOI: 10.1002/dad2.70040 |
0.333 |
|
| 2024 |
Nho K, Risacher SL, Apostolova LG, Bice PJ, Brosch JR, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, ... ... Mormino E, et al. CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET. Nature Communications. 15: 8251. PMID 39304655 DOI: 10.1038/s41467-024-52298-2 |
0.694 |
|
| 2024 |
Li JS, Tun SM, Ficek-Tani B, Xu W, Wang S, Horien CL, Toyonaga T, Nuli SS, Zeiss CJ, Powers AR, Zhao Y, Mormino EC, Fredericks CA. Medial amygdalar tau is associated with mood symptoms in preclinical Alzheimer's disease. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 39059466 DOI: 10.1016/j.bpsc.2024.07.012 |
0.318 |
|
| 2024 |
Johns E, Vossler HA, Young CB, Carlson ML, Winer JR, Younes K, Park J, Rathmann-Bloch J, Smith V, Harrison TM, Landau S, Henderson V, Wagner A, Sha SJ, Zeineh M, ... ... Mormino EC, et al. Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38962867 DOI: 10.1002/alz.13893 |
0.54 |
|
| 2024 |
Boyle R, Townsend DL, Klinger HM, Scanlon CE, Yuan Z, Coughlan GT, Seto M, Shirzadi Z, Yau WW, Jutten RJ, Schneider C, Farrell ME, Hanseeuw BJ, Mormino EC, Yang HS, et al. Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration. Alzheimer's Research & Therapy. 16: 148. PMID 38961512 DOI: 10.1186/s13195-024-01510-y |
0.448 |
|
| 2024 |
Li JS, Tun SM, Ficek-Tani B, Xu W, Wang S, Horien CL, Toyonaga T, Nuli SS, Zeiss CJ, Powers AR, Zhao Y, Mormino EC, Fredericks CA. Medial amygdalar tau is associated with anxiety symptoms in preclinical Alzheimer's disease. Biorxiv : the Preprint Server For Biology. PMID 38895308 DOI: 10.1101/2024.06.03.597160 |
0.314 |
|
| 2024 |
Abdelnour C, Young CB, Shahid-Besanti M, Smith A, Wilson EN, Ramos Benitez J, Vossler H, Plastini MJ, Winer JR, Kerchner GA, Cholerton B, Andreasson KI, Henderson VW, Yutsis M, Montine TJ, ... ... Mormino EC, et al. Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease. Annals of Neurology. PMID 38888142 DOI: 10.1002/ana.27003 |
0.304 |
|
| 2024 |
Seto M, Hohman TJ, Mormino EC, Papp KV, Amariglio RE, Rentz DM, Johnson KA, Schultz AP, Sperling RA, Buckley RF, Yang HS. Parental History of Memory Impairment and β-Amyloid in Cognitively Unimpaired Older Adults. Jama Neurology. PMID 38884955 DOI: 10.1001/jamaneurol.2024.1763 |
0.35 |
|
| 2024 |
Younes K, Smith V, Johns E, Carlson ML, Winer J, He Z, Henderson VW, Greicius MD, Young CB, Mormino EC. Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer's disease. Brain, Behavior, and Immunity. PMID 38710339 DOI: 10.1016/j.bbi.2024.05.002 |
0.405 |
|
| 2024 |
Winer JR, Lok R, Weed L, He Z, Poston KL, Mormino EC, Zeitzer JM. Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline. Alzheimer's Research & Therapy. 16: 35. PMID 38355598 DOI: 10.1186/s13195-024-01411-0 |
0.345 |
|
| 2023 |
Abiose O, Rutledge J, Moran-Losada P, Belloy ME, Wilson EN, He Z, Trelle AN, Channappa D, Romero A, Park J, Yutsis MV, Sha SJ, Andreasson KI, Poston KL, Henderson VW, ... ... Mormino EC, et al. Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38146099 DOI: 10.1002/alz.13576 |
0.396 |
|
| 2023 |
Younes K, Smith V, Johns E, Carlson ML, Winer J, He Z, Henderson VW, Greicius MD, Young CB, Mormino EC. Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer`s disease. Medrxiv : the Preprint Server For Health Sciences. PMID 37986964 DOI: 10.1101/2023.11.10.23296836 |
0.385 |
|
| 2023 |
Phongpreecha T, Godrich D, Berson E, Espinosa C, Kim Y, Cholerton B, Chang AL, Mataraso S, Bukhari SA, Perna A, Yakabi K, Montine KS, Poston KL, Mormino E, White L, et al. Quantitative estimate of cognitive resilience and its medical and genetic associations. Alzheimer's Research & Therapy. 15: 192. PMID 37926851 DOI: 10.1186/s13195-023-01329-z |
0.429 |
|
| 2023 |
Landau SM, Mormino EC. Tau Pathology Without Aβ-A Limited PART of Clinical Progression. Jama Neurology. PMID 37578768 DOI: 10.1001/jamaneurol.2023.1081 |
0.57 |
|
| 2023 |
Nho K, Risacher SL, Apostolova L, Bice PJ, Brosch J, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, ... ... Mormino E, et al. Novel Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET. Medrxiv : the Preprint Server For Health Sciences. PMID 36993271 DOI: 10.1101/2023.02.27.23286048 |
0.693 |
|
| 2023 |
Young CB, Mormino EC, Poston KL, Johnson KA, Rentz DM, Sperling RA, Papp KV. Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12414. PMID 36950699 DOI: 10.1002/dad2.12414 |
0.433 |
|
| 2023 |
Young CB, Johns E, Kennedy G, Belloy ME, Insel PS, Greicius MD, Sperling RA, Johnson KA, Poston KL, Mormino EC. APOE effects on regional tau in preclinical Alzheimer's disease. Molecular Neurodegeneration. 18: 1. PMID 36597122 DOI: 10.1186/s13024-022-00590-4 |
0.324 |
|
| 2022 |
Wilson EN, Young CB, Ramos Benitez J, Swarovski MS, Feinstein I, Vandijck M, Le Guen Y, Kasireddy NM, Shahid M, Corso NK, Wang Q, Kennedy G, Trelle AN, Lind B, Channappa D, ... ... Mormino EC, et al. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease. Alzheimer's Research & Therapy. 14: 172. PMID 36371232 DOI: 10.1186/s13195-022-01116-2 |
0.342 |
|
| 2022 |
Insel PS, Young CB, Aisen PS, Johnson KA, Sperling RA, Mormino EC, Donohue MC. Tau positron emission tomography in preclinical Alzheimer's disease. Brain : a Journal of Neurology. PMID 35962782 DOI: 10.1093/brain/awac299 |
0.38 |
|
| 2022 |
Eissman JM, Dumitrescu L, Mahoney ER, Smith AN, Mukherjee S, Lee ML, Scollard P, Choi SE, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski CC, ... ... Mormino EC, et al. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain : a Journal of Neurology. PMID 35552371 DOI: 10.1093/brain/awac177 |
0.318 |
|
| 2022 |
Young CB, Winer JR, Younes K, Cody KA, Betthauser TJ, Johnson SC, Schultz A, Sperling RA, Greicius MD, Cobos I, Poston KL, Mormino EC. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease. Jama Neurology. PMID 35435938 DOI: 10.1001/jamaneurol.2022.0676 |
0.383 |
|
| 2021 |
Young CB, Landau SM, Harrison TM, Poston KL, Mormino EC. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [F]-AV-1451 PET data. Neuroimage. 243: 118553. PMID 34487825 DOI: 10.1016/j.neuroimage.2021.118553 |
0.603 |
|
| 2021 |
Carlson ML, Toueg TN, Khalighi MM, Castillo J, Shen B, Azevedo EC, DiGiacomo P, Mouchawar N, Chau G, Zaharchuk G, James ML, Mormino EC, Zeineh MM. Hippocampal subfield imaging and fractional anisotropy show parallel changes in Alzheimer's disease tau progression using simultaneous tau-PET/MRI at 3T. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12218. PMID 34337132 DOI: 10.1002/dad2.12218 |
0.398 |
|
| 2021 |
Sendi MSE, Zendehrouh E, Fu Z, Liu J, Du Y, Mormino E, Salat D, Calhoun V, Miller RL. Disrupted dynamic functional network connectivity among cognitive control networks in the progression of Alzheimer's disease. Brain Connectivity. PMID 34102870 DOI: 10.1089/brain.2020.0847 |
0.32 |
|
| 2021 |
Lopes Alves I, Heeman F, Collij LE, Salvadó G, Tolboom N, Vilor-Tejedor N, Markiewicz P, Yaqub M, Cash D, Mormino EC, Insel PS, Boellaard R, van Berckel BNM, Lammertsma AA, Barkhof F, et al. Strategies to reduce sample sizes in Alzheimer's disease primary and secondary prevention trials using longitudinal amyloid PET imaging. Alzheimer's Research & Therapy. 13: 82. PMID 33875021 DOI: 10.1186/s13195-021-00819-2 |
0.362 |
|
| 2021 |
Trelle AN, Carr VA, Wilson EN, Swarovski MS, Hunt MP, Toueg TN, Tran TT, Channappa D, Corso NK, Thieu MK, Jayakumar M, Nadiadwala A, Guo W, Tanner NJ, Bernstein JD, ... ... Mormino EC, et al. Association of CSF Biomarkers with Hippocampal-dependent Memory in Preclinical Alzheimer Disease. Neurology. PMID 33408146 DOI: 10.1212/WNL.0000000000011477 |
0.787 |
|
| 2020 |
Sendi MSE, Zendehrouh E, Miller RL, Fu Z, Du Y, Liu J, Mormino EC, Salat DH, Calhoun VD. Alzheimer's Disease Projection From Normal to Mild Dementia Reflected in Functional Network Connectivity: A Longitudinal Study. Frontiers in Neural Circuits. 14: 593263. PMID 33551754 DOI: 10.3389/fncir.2020.593263 |
0.325 |
|
| 2020 |
Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, et al. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology. PMID 33199430 DOI: 10.1212/WNL.0000000000011214 |
0.384 |
|
| 2020 |
Dumitrescu L, Mahoney ER, Mukherjee S, Lee ML, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski C, Hernandez Saucedo H, Widaman KF, Buckley R, Properzi M, ... Mormino E, et al. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain : a Journal of Neurology. 143: 2561-2575. PMID 32844198 DOI: 10.1093/Brain/Awaa209 |
0.722 |
|
| 2020 |
Buckley RF, Scott MR, Jacobs HI, Schultz AP, Properzi MJ, Amarglio RE, Hohman TJ, Mayblyum DV, Rubinstein ZB, Manning L, Hanseeuw BJ, Mormino EC, Rentz DM, Johnson KA, Sperling RA. Sex mediates relationships between regional tau pathology and cognitive decline. Annals of Neurology. PMID 32799367 DOI: 10.1002/Ana.25878 |
0.373 |
|
| 2020 |
Carlson ML, DiGiacomo PS, Fan AP, Goubran M, Khalighi MM, Chao SZ, Vasanawala M, Wintermark M, Mormino E, Zaharchuk G, James ML, Zeineh MM. Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI. Scientific Reports. 10: 12064. PMID 32694602 DOI: 10.1038/S41598-020-69065-0 |
0.489 |
|
| 2020 |
Mormino EC, Toueg TN, Azevedo C, Castillo JB, Guo W, Nadiadwala A, Corso NK, Hall JN, Fan A, Trelle AN, Harrison MB, Hunt MP, Sha SJ, Deutsch G, James M, et al. Tau PET imaging with F-PI-2620 in aging and neurodegenerative diseases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32572562 DOI: 10.1007/S00259-020-04923-7 |
0.785 |
|
| 2020 |
Raghavan NS, Dumitrescu L, Mormino E, Mahoney ER, Lee AJ, Gao Y, Bilgel M, Goldstein D, Harrison T, Engelman CD, Saykin AJ, Whelan CD, Liu JZ, Jagust W, Albert M, et al. Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. Jama Neurology. PMID 32568366 DOI: 10.1001/Jamaneurol.2020.1760 |
0.532 |
|
| 2020 |
Trelle AN, Carr VA, Guerin SA, Thieu MK, Jayakumar M, Guo W, Nadiadwala A, Corso NK, Hunt MP, Litovsky CP, Tanner NJ, Deutsch GK, Bernstein JD, Harrison MB, Khazenzon AM, ... ... Mormino EC, et al. Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adults. Elife. 9. PMID 32469308 DOI: 10.7554/Elife.55335 |
0.747 |
|
| 2020 |
Insel PS, Mormino EC, Aisen PS, Thompson WK, Donohue MC. Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention. Brain Communications. 2: fcaa007. PMID 32140682 DOI: 10.1093/braincomms/fcaa007 |
0.364 |
|
| 2019 |
Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31759879 DOI: 10.1016/J.Jalz.2019.09.074 |
0.512 |
|
| 2019 |
Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 670-678. PMID 31673597 DOI: 10.1016/j.dadm.2019.08.004 |
0.367 |
|
| 2019 |
Sun N, Mormino EC, Chen J, Sabuncu MR, Yeo BT. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease. Neuroimage. 116043. PMID 31344486 DOI: 10.1016/J.Neuroimage.2019.116043 |
0.418 |
|
| 2019 |
Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. PMID 31289148 DOI: 10.1212/Wnl.0000000000007831 |
0.441 |
|
| 2019 |
Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, et al. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. Jama Neurology. PMID 31157827 DOI: 10.1001/Jamaneurol.2019.1424 |
0.454 |
|
| 2019 |
Buckley RF, Mormino EC, Chhatwal J, Schultz AP, Rabin JS, Rentz DM, Acar D, Properzi MJ, Dumurgier J, Jacobs H, Gomez-Isla T, Johnson KA, Sperling RA, Hanseeuw BJ. Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid. Neurobiology of Aging. 78: 178-185. PMID 30947113 DOI: 10.1016/J.Neurobiolaging.2019.02.019 |
0.326 |
|
| 2019 |
Yang HS, Chhatwal JP, Xu J, White CC, Hanseeuw B, Rabin JS, Papp KV, Buckley RF, Schultz AP, Properzi MJ, Gatchel JR, Amariglio RE, Donovan NJ, Mormino EC, Hedden T, et al. An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30883345 DOI: 10.3233/Jad-180788 |
0.345 |
|
| 2019 |
Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, Jacobs HIL, Papp KV, Amariglio RE, Properzi MJ, Schultz AP, Kirn D, Scott MR, Hedden T, Farrell M, et al. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults. Jama Neurology. PMID 30715078 DOI: 10.1001/Jamaneurol.2018.4693 |
0.608 |
|
| 2019 |
Tan CH, Bonham LW, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL, Yaffe K, Schellenberg GD, Kauppi K, Holland D, McEvoy LK, et al. Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration. Brain : a Journal of Neurology. PMID 30689776 DOI: 10.1093/Brain/Awy327 |
0.447 |
|
| 2019 |
Koran MEI, Davidzon G, Azevedo C, Toueg T, Nadiadwala A, Castillo JB, Hall JN, Sha S, Fredericks CA, Greicius MD, Wagner AD, Zaharchuk G, Chin FT, Mormino EC. P4-576: CONCORDANCE BETWEEN 18F-PI-2620 TAU PET/MRI IMAGING AND CLINICAL OUTCOMES IN ALZHEIMER DISEASE AND OTHER TAUOPATHIES Alzheimer's & Dementia. 15: P1541-P1541. DOI: 10.1016/J.Jalz.2019.08.124 |
0.773 |
|
| 2019 |
Papp KV, Buckley RF, Mormino EC, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz D, Sperling RA, Amariglio R. F2-03-01: CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID Alzheimer's & Dementia. 15: P518-P519. DOI: 10.1016/j.jalz.2019.06.4424 |
0.381 |
|
| 2019 |
Ying Lim YY, Sperling RA, Insel P, Maruff P, Johnson KA, Mormino EC. DISTINCT CONTRIBUTIONS OF BASELINE AND LONGITUDINAL AMYLOID PET MEASURES TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER ADULTS Alzheimer's & Dementia. 15: P179-P180. DOI: 10.1016/j.jalz.2019.06.4379 |
0.368 |
|
| 2019 |
Papp KV, Buckley RF, Mormino EC, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio R. P3-031: CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID Alzheimer's & Dementia. 15: P937-P938. DOI: 10.1016/J.Jalz.2019.06.3057 |
0.373 |
|
| 2018 |
Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T, Marshall GA, Quiroz YT, Donovan NJ, Jackson J, Gatchel JR, et al. The impact of Aβ and tau on prospective cognitive decline in older individuals. Annals of Neurology. PMID 30549303 DOI: 10.1002/Ana.25395 |
0.479 |
|
| 2018 |
Chen KT, Gong E, de Carvalho Macruz FB, Xu J, Boumis A, Khalighi M, Poston KL, Sha SJ, Greicius MD, Mormino E, Pauly JM, Srinivas S, Zaharchuk G. Ultra-Low-Dose F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs. Radiology. 180940. PMID 30526350 DOI: 10.1148/Radiol.2018180940 |
0.334 |
|
| 2018 |
Broce IJ, Tan CH, Fan CC, Jansen I, Savage JE, Witoelar A, Wen N, Hess CP, Dillon WP, Glastonbury CM, Glymour M, Yokoyama JS, Elahi FM, Rabinovici GD, Miller BL, ... Mormino EC, et al. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease. Acta Neuropathologica. PMID 30413934 DOI: 10.1007/S00401-018-1928-6 |
0.307 |
|
| 2018 |
Amariglio RE, Buckley RF, Mormino EC, Marshall GA, Johnson KA, Rentz DM, Sperling RA. Amyloid-associated increases in longitudinal report of subjective cognitive complaints. Alzheimer's & Dementia (New York, N. Y.). 4: 444-449. PMID 30258973 DOI: 10.1016/j.trci.2018.08.005 |
0.325 |
|
| 2018 |
Mormino EC, Jagust WJ. A New Tool for Clinical Neuroscience-Synaptic Imaging. Jama Neurology. PMID 30014142 DOI: 10.1001/jamaneurol.2018.1643 |
0.333 |
|
| 2018 |
Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, Bangen KJ, Delano-Wood L, Lamar M, Lim YY, Nudelman K, Zahodne L, Gross AL, Mungas D, Widaman KF, et al. Combined neuropathological pathways account for age-related risk of dementia. Annals of Neurology. PMID 29944741 DOI: 10.1002/Ana.25246 |
0.395 |
|
| 2018 |
Nebel RA, Aggarwal NT, Barnes LL, Gallagher A, Goldstein JM, Kantarci K, Mallampalli MP, Mormino EC, Scott L, Yu WH, Maki PM, Mielke MM. Understanding the impact of sex and gender in Alzheimer's disease: A call to action. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29907423 DOI: 10.1016/J.Jalz.2018.04.008 |
0.318 |
|
| 2018 |
Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29803541 DOI: 10.1016/J.Jalz.2018.04.010 |
0.403 |
|
| 2018 |
Hanseeuw BJ, Betensky RA, Mormino EC, Schultz AP, Sepulcre J, Becker JA, Jacobs HIL, Buckley RF, LaPoint MR, Vanini P, Donovan NJ, Chhatwal JP, Marshall GA, Papp KV, Amariglio RE, et al. PET staging of amyloidosis using striatum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29792874 DOI: 10.1016/J.Jalz.2018.04.011 |
0.319 |
|
| 2018 |
Mormino EC, Papp KV. Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29782318 DOI: 10.3233/JAD-179928 |
0.475 |
|
| 2018 |
Orlovsky I, Huijbers W, Hanseeuw BJ, Mormino EC, Hedden T, Buckley RF, LaPoint M, Rabin JS, Rentz DM, Johnson KA, Sperling RA, Papp KV. The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 121-129. PMID 29780861 DOI: 10.1016/J.Dadm.2017.11.003 |
0.323 |
|
| 2018 |
Hansson O, Mormino EC. Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials? Brain : a Journal of Neurology. 141: 1241-1244. PMID 29701788 DOI: 10.1093/brain/awy065 |
0.343 |
|
| 2018 |
Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino EC. Dissociable influences ofε4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. PMID 29592889 DOI: 10.1212/Wnl.0000000000005415 |
0.389 |
|
| 2017 |
Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5. Alzheimer's & Dementia (New York, N. Y.). 3: 668-677. PMID 29264389 DOI: 10.1016/j.trci.2017.10.004 |
0.396 |
|
| 2017 |
Tan CH, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Dillon WP, Bonham LW, Yokoyama JS, Karch CM, Brewer JB, Rabinovici GD, Miller BL, Schellenberg GD, Kauppi K, et al. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathologica. PMID 29177679 DOI: 10.1007/S00401-017-1789-4 |
0.396 |
|
| 2017 |
Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio RE. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. Jama Neurology. PMID 28973551 DOI: 10.1001/jamaneurol.2017.2216 |
0.422 |
|
| 2017 |
Lim YY, Mormino EC. APOE genotype and early β-amyloid accumulation in older adults without dementia. Neurology. PMID 28794245 DOI: 10.1212/WNL.0000000000004336 |
0.323 |
|
| 2017 |
Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, et al. Preclinical Alzheimer's disease and longitudinal driving decline. Alzheimer's & Dementia (New York, N. Y.). 3: 74-82. PMID 28435853 DOI: 10.1016/J.Trci.2016.11.006 |
0.438 |
|
| 2017 |
Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, Huijbers W, LaPoint M, Buckley RF, Johnson KA, Sperling RA. Phases of hyper and hypo connectivity in the Default Mode and Salience networks track with amyloid and Tau in clinically normal individuals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28314821 DOI: 10.1523/Jneurosci.3263-16.2017 |
0.413 |
|
| 2017 |
Papp KV, Rentz DM, Mormino EC, Schultz AP, Amariglio RE, Quiroz Y, Johnson KA, Sperling RA. Cued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology. PMID 28283594 DOI: 10.1212/Wnl.0000000000003812 |
0.392 |
|
| 2017 |
Hanseeuw BJ, Betensky RA, Schultz AP, Papp KV, Mormino EC, Sepulcre J, Bark JS, Cosio DM, LaPoint M, Chhatwal JP, Rentz DM, Sperling RA, Johnson K. FDG metabolism associated with tau-amyloid interaction predicts memory decline. Annals of Neurology. PMID 28253546 DOI: 10.1002/Ana.24910 |
0.373 |
|
| 2017 |
Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, et al. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated β-amyloid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28253478 DOI: 10.1016/J.Jalz.2017.01.018 |
0.402 |
|
| 2016 |
Hohman TJ, McLaren DG, Mormino EC, Gifford KA, Libon DJ, Jefferson AL. Asymptomatic Alzheimer disease: Defining resilience. Neurology. PMID 27815399 DOI: 10.1212/Wnl.0000000000003397 |
0.42 |
|
| 2016 |
Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KA. Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance. Brain Imaging and Behavior. PMID 27738998 DOI: 10.1007/s11682-016-9640-4 |
0.404 |
|
| 2016 |
Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT. Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 27702899 DOI: 10.1073/Pnas.1611073113 |
0.368 |
|
| 2016 |
Mormino EC, Papp KV, Rentz DM, Schultz AP, LaPoint M, Amariglio R, Hanseeuw B, Marshall GA, Hedden T, Johnson KA, Sperling RA. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. Jama Neurology. PMID 27548655 DOI: 10.1001/jamaneurol.2016.2237 |
0.352 |
|
| 2016 |
Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR. Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology. PMID 27385740 DOI: 10.1212/Wnl.0000000000002922 |
0.332 |
|
| 2016 |
Mormino EC, Papp KV. Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials. Jama Neurology. PMID 27064971 DOI: 10.1001/jamaneurol.2016.0281 |
0.366 |
|
| 2016 |
Jack CR, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ. Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nature Reviews. Neurology. PMID 26782335 DOI: 10.1038/Nrneurol.2015.251 |
0.544 |
|
| 2016 |
Mormino EC, Papp KV, Schultz AP, Hanseeuw BJ, Munro CE, Jaimes SY, Meneide T, Kilpatrick EP, Aghjayan SL, Jonas VH, Kirn D, Jackson JD, Amariglio R, Rentz DM, Sperling RA, et al. O4-01-06: Ab+ Clinically Normal Participants with Elevated Tau Show Greatest Decline in the Preclinical Alzheimer’s Disease Cognitive Composite Alzheimer's & Dementia. 12: P333-P334. DOI: 10.1016/J.Jalz.2016.06.611 |
0.335 |
|
| 2016 |
Rentz DM, Mormino EC, Papp KV, Johnson K, Sperling RA. F1-04-01: Longitudinal Peformance on the Preclinical Alzheimer’s Cognitive Composite (PACC) in Subjects with Biomarker-Defined Preclincal ad Alzheimer's & Dementia. 12: P167-P167. DOI: 10.1016/J.Jalz.2016.06.283 |
0.355 |
|
| 2016 |
Papp KV, Mormino EC, Amariglio R, Schultz AP, Quiroz YT, Jaimes SY, Aghjayan SL, Munro CE, Kilpatrick EP, Johnson K, Sperling RA, Rentz DM. P3-309: Profiles of Cognitive Decline Associated with Biomarker-Defined Preclinical Stages of Alzheimer’s Disease Alzheimer's & Dementia. 12: P960-P961. DOI: 10.1016/J.Jalz.2016.06.1973 |
0.341 |
|
| 2016 |
Lim YY, Mormino EC. P1-370: Effect of Aβ and APOE
E4 on Cognition, Hippocampal Volume and Aβ in Mild Cognitive Impairment Alzheimer's & Dementia. 12: P573-P573. DOI: 10.1016/j.jalz.2016.06.1122 |
0.366 |
|
| 2015 |
Papp KV, Mormino EC, Amariglio RE, Munro C, Dagley A, Schultz AP, Johnson KA, Sperling RA, Rentz DM. Biomarker Validation of a Decline in Semantic Processing in Preclinical Alzheimer's Disease. Neuropsychology. PMID 26595826 DOI: 10.1037/neu0000246 |
0.408 |
|
| 2015 |
Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, et al. Tau PET imaging in aging and early Alzheimer's disease. Annals of Neurology. PMID 26505746 DOI: 10.1002/Ana.24546 |
0.48 |
|
| 2015 |
Amariglio RE, Mormino EC, Pietras AC, Marshall GA, Vannini P, Johnson KA, Sperling RA, Rentz DM. Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly. Neurology. 85: 56-62. PMID 26048028 DOI: 10.1212/WNL.0000000000001712 |
0.328 |
|
| 2015 |
Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DM. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease. Neuropsychologia. 73: 169-75. PMID 26002757 DOI: 10.1016/j.neuropsychologia.2015.04.034 |
0.399 |
|
| 2015 |
Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, Okereke OI, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 25697700 DOI: 10.3233/JAD-142940 |
0.37 |
|
| 2015 |
Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, Amariglio RE, Marshall GA, Rentz DM, Johnson KA, Sperling RA. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain : a Journal of Neurology. 138: 1023-35. PMID 25678559 DOI: 10.1093/Brain/Awv007 |
0.388 |
|
| 2015 |
Rentz DM, Mormino EC, Amariglio R, Papp KV, Sperling RA, Johnson KA. O2-02-03: The relationship of cognition, cognitive reserve, and in vivo
tau and amyloid burden Alzheimer's & Dementia. 11: P175-P175. DOI: 10.1016/j.jalz.2015.07.138 |
0.337 |
|
| 2015 |
Schultz AP, Mormino EC, Chhatwal JP, LaPoint M, Dagley AS, Sperling RA, Johnson KA. O1-06-05: Baseline amyloid PET imaging, longitudinal amyloid accumulation, and Tau PET imaging in preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P139-P139. DOI: 10.1016/j.jalz.2015.07.061 |
0.36 |
|
| 2015 |
Schultz AP, Mormino EC, Chhatwal JP, LaPoint M, Dagley AS, Sperling RA, Johnson KA. IC-P-156: Baseline amyloid PET imaging, longitudinal amyloid accumulation, and Tau PET imaging in preclinical Alzheimer's disease Alzheimer's & Dementia. 11: P105-P105. DOI: 10.1016/J.Jalz.2015.06.179 |
0.365 |
|
| 2015 |
Rentz DM, Mormino EC, Amariglio R, Papp KV, Schultz AP, Sperling RA, Johnson KA. IC-P-068: The relationship of cognition, cognitive reserve, and in vivo
tau and amyloid burden Alzheimer's & Dementia. 11: P51-P51. DOI: 10.1016/j.jalz.2015.06.089 |
0.342 |
|
| 2014 |
Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron. 84: 608-22. PMID 25442939 DOI: 10.1016/J.Neuron.2014.10.038 |
0.5 |
|
| 2014 |
Hedden T, Schultz AP, Rieckmann A, Mormino EC, Johnson KA, Sperling RA, Buckner RL. Multiple Brain Markers are Linked to Age-Related Variation in Cognition. Cerebral Cortex (New York, N.Y. : 1991). PMID 25316342 DOI: 10.1093/cercor/bhu238 |
0.329 |
|
| 2014 |
Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA. Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. Jama Neurology. 71: 1379-85. PMID 25222039 DOI: 10.1001/jamaneurol.2014.2031 |
0.37 |
|
| 2014 |
Mormino EC. The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations. Neuropsychology Review. 24: 300-12. PMID 25108368 DOI: 10.1007/s11065-014-9267-4 |
0.378 |
|
| 2014 |
Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology. 82: 1760-7. PMID 24748674 DOI: 10.1212/Wnl.0000000000000431 |
0.396 |
|
| 2014 |
Huijbers W, Mormino EC, Wigman SE, Ward AM, Vannini P, McLaren DG, Becker JA, Schultz AP, Hedden T, Johnson KA, Sperling RA. Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 5200-10. PMID 24719099 DOI: 10.1523/Jneurosci.3579-13.2014 |
0.384 |
|
| 2014 |
Sperling R, Mormino E, Schultz A, Rentz D, Aisen P, Johnson K. The Aging Brain - Does Amyloid Matter? Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.111 |
0.324 |
|
| 2014 |
Johnson KA, Mormino E, Rentz DM, Schultz A, Becker JA, Sepulcre J, Chhatwal J, Amariglio R, Papp K, Marshall G, Shoup T, Yokell D, Brady T, Hyman B, Vasdev N, et al. DT-01-02: TEMPORAL NEOCORTICAL TAU DEPOSITION MEASURED WITH PET IS ASSOCIATED WITH LONGITUDINAL DECLINE IN MEMORY PERFORMANCE AMONG CLINICALLY NORMAL ELDERLY Alzheimer's & Dementia. 10: P280-P280. DOI: 10.1016/J.Jalz.2014.07.150 |
0.542 |
|
| 2014 |
Rentz DM, Papp KV, Mormino EC, Amariglio RE, Becker JA, Schultz AP, Johnson KA, Sperling RA. IC-P-087: DETECTING COGNITIVE PROFILES IN THE BIOMARKER STAGES OF PRECLINICAL AD Alzheimer's & Dementia. 10: P49-P50. DOI: 10.1016/j.jalz.2014.05.092 |
0.306 |
|
| 2014 |
Amariglio RE, Mormino E, Vannini P, Marshall G, Johnson KA, Sperling RA, Rentz DM. Greater Subjective Cognitive Concerns Correspond With Advancing Stages Of Preclinical Ad Alzheimers & Dementia. 10: 4. DOI: 10.1016/J.Jalz.2014.04.024 |
0.43 |
|
| 2013 |
Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, Gorno-Tempini ML, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 11606-11. PMID 23798398 DOI: 10.1073/Pnas.1221536110 |
0.512 |
|
| 2013 |
Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 687-698.e1. PMID 23474040 DOI: 10.1016/J.Jalz.2012.10.012 |
0.807 |
|
| 2013 |
Mormino E, Rentz D, Amariglio R, Hedden T, Schultz A, Ward A, Marshall G, Chhatwal J, Donovan N, Papp K, Boot B, Meneide T, Lorius N, Wigman S, Younger A, et al. P2-142: Short-term predictors of clinical progression in the Harvard Aging Brain Study Alzheimer's & Dementia. 9: P397-P398. DOI: 10.1016/J.Jalz.2013.05.786 |
0.304 |
|
| 2013 |
Ward A, Mormino E, Schultz A, Hedden T, Johnson K, Sperling R. IC-P-188: Entorhinal thickness mediates the relationship between hippocampus volume and default-mode network connectivity independently of amyloid burden in cognitively intact elderly Alzheimer's & Dementia. 9: P106-P107. DOI: 10.1016/J.Jalz.2013.05.187 |
0.392 |
|
| 2013 |
Wigman S, Mormino E, Schultz A, Ward A, Amariglio R, Huijbers W, Rentz D, Johnson K, Sperling R, Vannini P. IC-P-081: Differential anatomical correlates of objective and subjective memory in older individuals across a spectrum of memory impairment Alzheimer's & Dementia. 9: P49-P49. DOI: 10.1016/J.Jalz.2013.05.078 |
0.31 |
|
| 2013 |
Huijbers W, Ward A, Wigman S, Mormino E, Vannini P, Becker J, Schultz A, Johnson K, Hedden T, Sperling R. IC-P-013: Dissociations between entorhinal and hippocampal activity in cognitively normal older adults with and without beta-amyloid deposition Alzheimer's & Dementia. 9: P17-P17. DOI: 10.1016/J.Jalz.2013.05.014 |
0.403 |
|
| 2013 |
Mormino E, Vannini P, Amariglio R, Schultz A, Marshall G, Johnson K, Sperling R, Rentz D. O1-04-04: Subjective cognitive concerns, amyloid burden and cognitive reserve Alzheimer's & Dementia. 9: P133-P134. DOI: 10.1016/J.Jalz.2013.04.070 |
0.416 |
|
| 2013 |
Rentz D, Hedden T, Mormino E, Amariglio R, Becker J, Schultz A, Marshall G, Sperling R, Johnson K. IC-O2-02: Detecting cognitive evidence of preclinical Alzheimer's disease Alzheimer's & Dementia. 9: P6-P6. DOI: 10.1016/J.Jalz.2013.04.022 |
0.43 |
|
| 2012 |
Habeck C, Risacher S, Lee GJ, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, DeCarli C, Saykin AJ, Crane PK. Relationship between baseline brain metabolism measured using [¹â¸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging and Behavior. 6: 568-83. PMID 23179062 DOI: 10.1007/S11682-012-9208-X |
0.512 |
|
| 2012 |
Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker JA, Buckner RL, Johnson KA, Sperling RA, Rentz DM. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 16233-42. PMID 23152607 DOI: 10.1523/JNEUROSCI.2462-12.2012 |
0.398 |
|
| 2012 |
Nho K, Risacher SL, Crane PK, DeCarli C, Glymour MM, Habeck C, Kim S, Lee GJ, Mormino E, Mukherjee S, Shen L, West JD, Saykin AJ. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease. Brain Imaging and Behavior. 6: 551-67. PMID 23070747 DOI: 10.1007/S11682-012-9203-2 |
0.525 |
|
| 2012 |
Mukherjee S, Kim S, Gibbons LE, Nho K, Risacher SL, Glymour MM, Habeck C, Lee GJ, Mormino E, Ertekin-Taner N, Montine TJ, Decarli C, Saykin AJ, Crane PK. Genetic architecture of resilience of executive functioning. Brain Imaging and Behavior. 6: 621-33. PMID 22711244 DOI: 10.1007/S11682-012-9184-1 |
0.434 |
|
| 2012 |
Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Archives of Neurology. 69: 223-9. PMID 22332189 DOI: 10.1001/archneurol.2011.666 |
0.563 |
|
| 2012 |
Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ. Association of lifetime cognitive engagement and low β-amyloid deposition. Archives of Neurology. 69: 623-29. PMID 22271235 DOI: 10.1001/Archneurol.2011.2748 |
0.785 |
|
| 2012 |
Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ. Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cerebral Cortex (New York, N.Y. : 1991). 22: 1813-23. PMID 21945849 DOI: 10.1093/Cercor/Bhr255 |
0.43 |
|
| 2012 |
Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 59: 1152-60. PMID 21884802 DOI: 10.1016/J.Neuroimage.2011.07.098 |
0.419 |
|
| 2012 |
Wirth M, Oh H, Mormino EC, Landau S, Jagust W. O1-10-02: Beta-amyloid deposition in normal elderly is related to longitudinal but not cross-sectional cognitive decline Alzheimer's & Dementia. 8: P102-P102. DOI: 10.1016/J.Jalz.2012.05.258 |
0.749 |
|
| 2011 |
Rabinovici GD, Rosen HJ, Alkalay A, Kornak J, Furst AJ, Agarwal N, Mormino EC, O'Neil JP, Janabi M, Karydas A, Growdon ME, Jang JY, Huang EJ, Dearmond SJ, Trojanowski JQ, et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology. 77: 2034-42. PMID 22131541 DOI: 10.1212/Wnl.0B013E31823B9C5E |
0.47 |
|
| 2011 |
Jagust WJ, Mormino EC. Lifespan brain activity, β-amyloid, and Alzheimer's disease. Trends in Cognitive Sciences. 15: 520-6. PMID 21983147 DOI: 10.1016/j.tics.2011.09.004 |
0.588 |
|
| 2011 |
Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 76: 1789-96. PMID 21525424 DOI: 10.1212/Wnl.0B013E31821Cccad |
0.535 |
|
| 2011 |
Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust WJ. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cerebral Cortex (New York, N.Y. : 1991). 21: 2399-407. PMID 21383234 DOI: 10.1093/Cercor/Bhr025 |
0.518 |
|
| 2011 |
Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ. β-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage. 54: 1887-95. PMID 20965254 DOI: 10.1016/J.Neuroimage.2010.10.027 |
0.755 |
|
| 2010 |
Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain : a Journal of Neurology. 133: 512-28. PMID 20080878 DOI: 10.1093/Brain/Awp326 |
0.542 |
|
| 2009 |
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain : a Journal of Neurology. 132: 1310-23. PMID 19042931 DOI: 10.1093/Brain/Awn320 |
0.552 |
|
| 2009 |
Furst AJ, Mormino EC, Steed T, Rostomian AH, Mathis CA, Jack CR, Jagust WJ. IC-P-076: Hippocampal volume loss is associated with increased A-beta levels in the precuneus in mild cognitive impairment Alzheimer's & Dementia. 5: P35-P36. DOI: 10.1016/j.jalz.2009.05.630 |
0.449 |
|
| 2009 |
Mormino EC, Smiljic A, Baker SL, Hayenga AO, Madison CM, Jagust WJ. O2-01-01: Beta-amyloid deposition is related to default mode network connectivity in normal controls Alzheimer's & Dementia. 5: P100-P100. DOI: 10.1016/J.Jalz.2009.05.316 |
0.369 |
|
| 2008 |
Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Annals of Neurology. 64: 388-401. PMID 18991338 DOI: 10.1002/Ana.21451 |
0.517 |
|
| 2008 |
Rabinovici GD, Furst AJ, Mormino EC, O'Neil JP, Steed T, Turken M, Kluth J, Madison C, Miller BL, Jagust WJ. P1-280: Amyloid and glucose metabolism in early versus late-onset Alzheimer's disease: A comparative [11C]PIBand [18F]FDG PET study Alzheimer's & Dementia. 4: T299-T299. DOI: 10.1016/J.Jalz.2008.05.870 |
0.501 |
|
| 2008 |
Mormino EC, Hayenga AO, Madison CM, Kluth JT, Furst AJ, Rabinovici GD, Jagust WJ. P1-267: Metabolic evidence of compensation for amyloid pathology in nondemented elderly individuals Alzheimer's & Dementia. 4: T295-T295. DOI: 10.1016/j.jalz.2008.05.857 |
0.444 |
|
| 2008 |
Rabinovici GD, Furst AJ, Mormino EC, O'Neil JP, Steed T, Turken M, Kluth J, Madison C, Miller BL, Jagust WJ. IC-01-06: Amyloid and glucose metabolism in early versus late-onset AD: A comparative [11C]PIB and [18F]FDG PET study Alzheimer's & Dementia. 4: T4-T4. DOI: 10.1016/J.Jalz.2008.05.2492 |
0.461 |
|
| 2007 |
Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 68: 1205-12. PMID 17420404 DOI: 10.1212/01.Wnl.0000259035.98480.Ed |
0.538 |
|
| 2006 |
Mormino EC, Nadiadwala A, Azevedo C, Guo W, Castillo JB, Hall JN, Trelle AN, Sha S, Jayakumar M, Tanner N, Harrison M, Deutsch G, Fredericks CA, Greicius MD, Srinivas SM, et al. P4-315: TAU PET IMAGING WITH 18
F-PI2620 IN AGING AND ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1577-P1578. DOI: 10.1016/J.Jalz.2018.07.138 |
0.779 |
|
| 2006 |
Insel P, Weiner M, Mackin S, Mormino EC, Lim Y, Stomrud E, Palmqvist S, Masters CL, Maruff P, Hansson O, Mattsson N. DT-01-06: COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER'S DISEASE: A COMPARISON AND SYNTHESIS OF LARGE INTERNATIONAL COHORTS Alzheimer's & Dementia. 14: P1667-P1668. DOI: 10.1016/J.Jalz.2018.07.008 |
0.398 |
|
| Show low-probability matches. |